Global Hormone Replacement Therapy (HRT) Market By Route of Administration: Oral, Transdermal, Parenteral

Global Hormone Replacement Therapy (HRT) Market to Reach USD 29.65 billion by 2028
According to the latest research by SkyQuest Technology, the Global Hormone Replacement Therapy (HRT) Market was valued at USD 14.98 billion in 2021, and it is expected to reach USD 29.65 billion by 2028, with a CAGR of 5.7% during the forecast period of 2022-2028. The research provides up-to-date Hormone Replacement Therapy (HRT) market analysis of the current market landscape, latest trends, drivers, and overall market environment.

Get report : https://skyquestt.com/report/hormone-replacement-therapy-market

Women's menopause-related disorders have been successfully treated for many years with hormone replacement treatment. Hot flashes, osteoporosis dangers, and other menopause symptoms have also diminished as a result. The market for these treatments is also growing as a result of the development in other hormone-related disorders that affect both men and women and are targeted at different age groups. As a result, conditions including thyroid problems, growth deficits, and others are predicted to hasten market expansion globally throughout the forecast period.

The market for hormone replacement treatment (HRT) is growing due to the availability of long-acting HGH products and other elements such as the rising prevalence of target disorders. According to the American Thyroid Association, 12 percent of Americans will eventually have thyroid illness. It further mentioned that over 20 million Americans have thyroid problems. Numerous studies showed that those undergoing HRT likely had a low risk of COVID-19 infection and mortality.

Download Sample Report : https://skyquestt.com/sample-request/hormone-replacement-therapy-market

Read Market Research Report, "Global Hormone Replacement Therapy (Hrt) Market by Therapy Type (Estrogen & Combinations Replacement Therapy, Thyroid Hormone Replacement Therapy, Growth Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy Segments), Indication (Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency), Route Of Administration (Oral, Transdermal, Parenteral Route), and Region -Forecast and Analysis 2022-2028" by SkyQuest.

Estrogen and combined hormone replacement treatment have dominated the market expansion due to the rising usage of these improved therapies, the accessibility of these drugs in a range of formulations, and the increased awareness of menopause symptoms worldwide. Growth hormone replacement therapy is expected to support a sizable CAGR during the foreseeably near future. Due to an increase in the prevalence of growth hormone deficiencies in significant countries, there is a rising demand for growth hormone therapies, which are safe and effective in comparison to low risks like fluid retention, peripheral edema, carpal tunnel syndrome, glucose intolerance, and others. Additionally, the drugs in this therapeutic area bring in more money from the market.

The transdermal segment is expected to grow at a relatively high CAGR over the course of the projection period as a result of the introduction of novel gel formation therapies that hold more effectively without any risk in the treatment. For instance, Gedeon Richter revealed that Lenzetto, a transdermal spray containing estradiol, is now available in the UK. The spray helps postmenopausal women manage and treat the signs and symptoms of oestrogen deficiency. The parenteral sector is predicted to have the lowest CAGR during the projection period.

Asia Pacific now has the greatest market share and is predicted to maintain that position during the forecast. The fact that the area is home to important consumers like China and India has something to do with this. According to Reliance Industries Limited, the demand for PE grew by 4%. The nation's market is expanding as a result of rising demand from industries including packaging and infrastructure & construction.

Report Findings
● Drivers- The treatments are essential for a variety of patients, including those with growth hormone shortages, menopausal issues in women, and hypogonadism in the elderly. The medication is offered in many different formats, including skin and buccal patches, injections, tablets, and others. Hence, advanced solutions are in high demand and thereby increasing market growth.
● Restraint- The growth of the market is being hampered by some issues. Treatments come in a wide range of forms, including patches, gel, pills, and injections. The potential negative effects of these treatments, which include a rise in cholesterol levels, blood clots, bloating, edema, and other issues, could, however, impede the market's growth.

Speak with our analyst for more information: https://skyquestt.com/speak-with-analyst/hormone-replacement-therapy-market

What does this Report Deliver?
● Market Estimation for 20+ Countries
● Hormone Replacement Therapy (HRT) Market demand by Region, Sub-Region, and Country
● Customization on Segments, Regions, and Company Profiles
● 100+ tables, 150+ Figures
● Global, Regional and Country specific Hormone Replacement Therapy (HRT) Market Trends
● Comprehensive Mapping of Hormone Replacement Therapy (HRT) Industry Parameters
● Attractive Investment Proposition in the Global Hormone Replacement Therapy (HRT) Industry
● Competitive Strategies Adopted by Hormone Replacement Therapy (HRT) Market Key Players
● Drivers, Restraints, Opportunities, Challenges and the impact on the Hormone Replacement Therapy (HRT) Market Size
● Market growth rate till 2028
● Regulatory scenario, regional dynamics, and Hormone Replacement Therapy (HRT) market insights of leading countries in each region
● In-depth Market insights by Region and Country
● Market Segmentation Trend Analysis, Opportunities and Growth
● Porter's five force analysis to know the market's condition
● Pricing Analysis and Hormone Replacement Therapy (HRT) Market Sales
● Parent market analysis
● Product portfolio benchmarking

SkyQuest has segmented the Global Hormone Replacement Therapy (HRT) Market based on Therapy Type, Indication, Route of Administration and Region:
Global Hormone Replacement Therapy (HRT) by Therapy Type (Revenue, US$ billion, 2021 - 2028)
● Estrogen & Combinations Replacement Therapy
● Thyroid Hormone Replacement Therapy
● Growth Hormone Replacement Therapy
● Testosterone Hormone Replacement Therapy
Global Hormone Replacement Therapy (HRT) by Indication (Revenue, US$ billion, 2021 - 2028)
● Menopause
● Hypothyroidism
● Male Hypogonadism
● Growth Hormone Deficiency
Global Hormone Replacement Therapy (HRT) by Route of Administration (Revenue, US$ billion, 2021 - 2028)
● Oral
● Transdermal
● Parenteral
Global Hormone Replacement Therapy (HRT) by Region (Revenue, US$ billion, 2021 - 2028)
○ North America
■ US
■ Canada
○ Europe
■ Germany
■ France
■ UK
■ Italy
■ Spain
■ Rest of Europe
○ Asia Pacific
■ China
■ India
■ Japan
■ Rest of Asia Pacific
○ Central & South America
■ Brazil
■ Rest of CSA
○ Middle East & Africa
■ GCC Countries
■ South Africa
■ Rest of MEA

Key Players in the Global Hormone Replacement Therapy (HRT) Market
● Eli Lilly and Company (US)
● Bayer AG (Germany)
● Noven Pharmaceuticals, Inc. (US)
● Pfizer Inc. (US)
● Merck & Co., Inc. (Germany)
● Viatris, Inc. (US)
● Novo Nordisk A/S (Denmark)
● Hoffmann-La Roche Ltd. (Switzerland)
● ASCEND Therapeutics US, LLC. (US)
● AbbVie, Inc. (US)
● Mithra Pharmaceuticals (Belgium)
● Endo International PLC (Ireland)

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Address:

1 Apache Way, Westford, Massachusetts 01886

Phone:

USA (+1) 617-230-0741

Email: sales@skyquestt.com

This release was published on openPR.